Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes
- Conditions
- Obesity
- Interventions
- Behavioral: Standard Lifestyle InterventionBehavioral: Modified Lifestyle Intervention
- Registration Number
- NCT04073394
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this protocol is to define an "individualized diet" approach based on obesity related phenotypes (pathophysiology obesity classification), which would increase weight loss, adherence, and weight loss maintenance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 215
- Adults with obesity (BMI >30Kg/m2); these will be otherwise healthy individuals with no unstable psychiatric disease and uncontrolled life-threatening comorbidities (i.e. unstable angina).
- Age: 18-65 years.
- Gender: Men or women.
- Weight change greater than 3% in the previous 3 months (weight stable).
- History of bariatric surgery including lap band and bariatric endoscopy.
- Significant untreated psychiatric dysfunction including binge eating disorders and bulimia.
- Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM
- A positive score on the AUDIT-C questionnaire as judged by an investigator.
- Patient has a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder study adherence
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Standard Lifestyle Intervention Standard Lifestyle Intervention Participants in this group will be instructed to follow a standard low calorie diet, recommended to have 30 minutes of physical activity 3-5 days per week, and will be followed by a wellness couch weekly. Modified Lifestyle Intervention Modified Lifestyle Intervention Participants in this group will have a tailored diet, exercise, and behavioral plan according to their obesity phenotype.
- Primary Outcome Measures
Name Time Method 12-week total body weight loss 12 weeks Change in body weight during the 12 week study
- Secondary Outcome Measures
Name Time Method Gastric Emptying 2 Hours 12 weeks Change in gastric emptying percentage at 2 hours during the 12 week study using scintigraphy
Waist Circumference 12 weeks Change in waist circumference (cm)
Responder Rate 12 weeks Proportion of patients losing \> 3% of total body weight
Fat Loss 12 weeks Change in fat mass during the 12 week study using DEXA
Gastric Emptying 12 weeks Change in half gastric emptying time during the 12 week study using scintigraphy
Adherence 12 weeks Adherence and compliance with program defined by the number of contacts with the team
Calorie Intake 12 weeks Change in daily calorie intake
Anxiety Level 12 weeks Change is anxiety level during the 12 week study using the HADS-A scale
Emotional Eating 12 weeks Change is emotional eating level during the 12 week study using the TFEQ score
Calories to Fullness 12 weeks Change in calories consumed to fullness during the 12 week study using satiation test
Resting Metabolic Rate 12 weeks Change in resting energy expenditure during the 12 week study using an indirect calorimetry
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States